Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Veritas Genetics International Ltd.
DescriptionSaliva-based genetic screening test for breast cancer 1 early onset (BRCA1) and breast cancer 2 early onset (BRCA2) gene mutations
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect mutations in BRCA1 and BRCA2 genes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today